You are not logged in.
LoginRashid Khan
The Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) Mitral Trial is one of the largest studies ever conducted with mechanical mitral valves involving 401 patients (mean age 55 y/o) at 44 North American centers.
The On-X Mechanical Mitral Valve, which is engineered for exceptional clinical performance, now has the most robust body of evidence supporting its use as demonstrated by sustained quality of life improvements in PROACT Mitral.
On-X Mitral Heart Valves should be managed at current guideline recommendations of 2.5-3.5 INR
On-X is manufactured in Austin, USA by Artivion ( Formerly CryoLife ), USA.
Advertisement